PRCT
PROCEPT BioRobotics Corp. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website rocept-biorobotics.com
- Employees(FY) 428
- ISIN US74276L1052
Performance
-9.62%
1W
-13.25%
1M
-1.96%
3M
+30.92%
6M
+93.68%
YTD
+102.92%
1Y
Profile
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
Technical Analysis of PRCT 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-06 16:22
- 2024-12-02 16:19
- 2024-12-02 08:08
- 2024-11-29 11:15
- 2024-11-28 22:15
- 2024-11-26 16:05
- 2024-11-26 03:05
- 2024-11-15 16:32
- 2024-11-14 14:02
- 2024-11-07 12:00
- 2024-11-01 14:27
These IBD 50 Leaders Melt Gains As Stock Market Wavers(Investor's Business Daily)
- 2024-10-31 17:22
- 2024-10-30 04:29
- 2024-10-29 20:43
- 2024-10-29 12:00
- 2024-10-29 11:56
Medical Gear Stock Surges Past Buy Point On Upbeat Sales Outlook(Investor's Business Daily)
- 2024-10-29 09:12
- 2024-10-29 08:43
- 2024-10-29 07:28
PROCEPT BioRobotics Third Quarter 2024 Earnings: Beats Expectations(Simply Wall St.)
- 2024-10-29 05:18
- 2024-10-29 03:03
- 2024-10-28 16:19
- 2024-10-28 15:36
Sector Update: Health Care(MT Newswires)
- 2024-10-28 14:17
- 2024-10-28 11:39
PROCEPT BioRobotics Jumps 30% Today on Massive Revenue Surge(GuruFocus.com)
- 2024-10-28 07:00
- 2024-10-28 07:00
- 2024-10-28 04:19
- 2024-10-27 21:27
- 2024-10-27 20:10
Page 1 of 8
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.